This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jean G. Dumesnil, MD; Kien Tran, MD; Gilles R. Dagenais, MD

Arch Intern Med. 1990;150(4):757-760.

Abstract
• The long-term effects of vasodilators in asymptomatic patients with aortic regurgitation have not been studied extensively. We retrospectively reviewed the echocardiograms of 19 asymptomatic patients with significant aortic regurgitation followed up annually for up to 4 years (average ± SD, 3.1 ± 0.7 years). Of these 19 patients, 12 were not receiving vasodilators and 7 were receiving hydralazine hydrochloride, 40 to 200 mg daily. In the patients not receiving vasodilators, left ventricular diastolic and systolic dimensions increased progressively in all patients by an average of 8% and 13%, respectively, after 3 years. In the patients receiving hydralazine, left ventricular dimensions increased by 9% and 5% in the year or more before hydralazine use and decreased by 7% and 7%, respectively, during the first year after using hydralazine. The reduction was observed in all patients during the first year, but an increase was detected in 3 patients followed up beyond that period. The results suggest that the progression of left ventricular dilatation in asymptomatic patients with aortic regurgitation can be delayed by long-term therapy with vasodilators. Pending further confirmation, such therapy may possibly influence the natural history of the disease and delay the timing of operation.

(Arch intern Med. 1990;150:757-760)

Author Affiliations
From the Québec Heart Institute, Department of Medicine, Laval University, Sainte-Foy, Canada.

Footnotes
Accepted for publication October 30,1989.

Read in part at the 37th Annual Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 30,1988.

Reprint requests to Québec Heart Institute, 2725 Chemin Sainte-Foy, Sainte-Foy, Québec, Canada G1V 4G5 (Dr Dumesnil).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Valvular Heart Disease: Aortic Regurgitation
Bekeredjian and Grayburn
Circulation 2005;112:125-134.
ABSTRACT | FULL TEXT